Latest

psychopharmacology

Featured Neuroscience Open Neuroscience Articles Psychology

·November 27, 2021·5 min read

Looking to Mitochondria for Clues About Depression

People with untreated depression have lower levels of mitochondrial proteins. For those who responded to the SSRI antidepressants, the proteins returned to a normal level, but showed no increase in those who did not respond to medication.

This shows a young woman looking depressed with a drink in her hand

Featured Neuroscience Open Neuroscience Articles Psychology

·November 23, 2021·3 min read

Psilocybin Reduces Relapses for Those With Alcohol Use Disorder

Psilocybin can restore mGluR2 levels in the prefrontal cortex, and this leads to a reduced risk of relapse for those with alcohol use disorder.

Featured Neuroscience Open Neuroscience Articles Psychology

·November 23, 2021·4 min read

Psychedelic Microdosing Improves Mental Health

Microdosing psychedelics like LSD and psilocybin alleviates symptoms of depression and anxiety while improving feelings of wellbeing.

Featured Neuroscience Psychology

·November 19, 2021·5 min read

Psychedelics Show Promise in Treating Mental Illness

A growing body of evidence suggests psychedelics including psilocybin and LSD show promise in providing lasting relief from symptoms for those suffering some mental health disorders. Researchers found DOI, a similar drug to LSD, reduced negative behavioral responses following fear triggers in mouse models of anxiety.

This shows the outline of a woman and a brain

Featured Neuroscience Psychology

·November 12, 2021·3 min read

New Target Identified for Rapid Antidepressant Drugs

Ketamine's rapid antidepressant action is due to specific synaptic effects, researchers report.

Featured Neuroscience Psychology

·November 9, 2021·5 min read

New Imaging Biomarkers That Predict Antidepressant Response Identified

Combining neuroimaging and artificial intelligence, researchers identified novel brain signatures unique to the response of each antidepressant.

Featured Neuroscience Open Neuroscience Articles Psychology

·November 8, 2021·4 min read

Expectations and Dopamine Can Affect Outcome of SSRI Antidepressant Treatment

The placebo effect combined with dopamine levels can determine whether symptoms of depression and social anxiety will improve in patients prescribed SSRI antidepressants. Researchers found the positive effect of the medications was four times higher in patients with high expectations the treatment would work compared to those with lower expectations.

Featured Neurology Neuroscience

·October 22, 2021·4 min read

Common Antidepressant Should No Longer Be Used to Treat People With Dementia

Mirtazapine, an antidepressant commonly prescribed to treat dementia-associated agitation, is no more effective than a placebo and may increase mortality risks, researchers report.

Auditory Neuroscience Featured Neuroscience Psychology

·October 5, 2021·4 min read

Psilocybin Affects Perception of Music

Psilocybin, a natural psychoactive compound currently being considered for the treatment of depression, alters people's emotional states while listening to music. While listening to music, those who used psilocybin reported enhanced emotional processing. Researchers say combining music with psychedelic therapy may have positive benefits for those suffering from depression.

Featured Neuroscience Open Neuroscience Articles Psychology

·September 27, 2021·4 min read

Psychedelics Linked to Social Bonding and Prosocial Behaviors in Ravers

Drums, dance, sleep deprivation, and drugs, referred to as the 4D's in the rave scene was associated with personal transformation for those who considered a rave to be an awe-inspiring event. The more a person felt personally transformed by the experience, the more bonded to the fellow ravers they felt. This phenomenon may explain the long-standing popularity of the rave scene.